Srinivas Annavarapu

Combination of the histone deacetylase inhibitor LBH589 and the hsp90 inhibitor 17-AAG is highly active against human CML-BC cells and AML cells with activating mutation of FLT-3

Prince George, Purva Bali, Srinivas Annavarapu et al. · Blood · 2004 · 324 citations

Life Sciences, Molecular Biology, Oncology +14

Mechanistic role of heat shock protein 70 in Bcr-Abl–mediated resistance to apoptosis in human acute leukemia cells

Fei Guo, Celia Sigua, Purva Bali et al. · Blood · 2004 · 173 citations · Full text

Life Sciences, Cell Biology, Molecular Biology +17

Superior Activity of the Combination of Histone Deacetylase Inhibitor LAQ824 and the FLT-3 Kinase Inhibitor PKC412 against Human Acute Myelogenous Leukemia Cells with Mutant FLT-3

Purva Bali, Prince George, Pamela Cohen et al. · Clinical Cancer Research · 2004 · 125 citations · Full text

Medicine, Molecular Biology, Oncology +17

Cotreatment with 17-Allylamino-Demethoxygeldanamycin and FLT-3 Kinase Inhibitor PKC412 Is Highly Effective against Human Acute Myelogenous Leukemia Cells with Mutant FLT-3

Prince George, Purva Bali, Pamela Cohen et al. · Cancer Research · 2004 · 122 citations · Full text

Medicine, Oncology, Pharmacology +17

Impact of comorbid conditions in COPD patients on health care resource utilization and costs in a predominantly Medicare population

Phil Schwab, Amol D. Dhamane, Sari Hopson et al. · International Journal of COPD · 2017 · 68 citations · Full text

Medicine, Clinical Sciences, Internal Medicine +17